LONA
$11.30
Pre-MarketAs of Mar 17, 8:00 PM UTC
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
Historical Price
Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$11.30
Potential Upside
5%
Whystock Fair Value$11.87
Price
UndervaluedFair ValueOvervalued
Fundamentals
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$105.50M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.76
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-89.42%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
9.05
Recent News
No recent news found.